1-3 of 3
Howard M. Stern, M.D., Ph.D
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Treatment With The Potent PI3K-δ,γ Inhibitor IPI-145 Is Associated With Rapid Decreases In Specific Cytokines, Chemokines and Matrix Metalloproteinases In The Serum Of Patients With Chronic Lymphocytic Leukemia and Indolent Non-Hodgkin Lymphoma

Mark Douglas, M.S., Ken Allison, M.S., Synder Ted, B.A., Kerstin Allen, MA, Brad S. Kahl, MD, Steven M. Horwitz, MD, Ian W. Flinn, MD, PhD, Patrick Kelly, MD, Howard M. Stern, M.D., Ph.D
Journal: Blood
Blood (2013) 122 (21): 1633.
https://doi.org/10.1182/blood.V122.21.1633.1633
Published: 2013
Journal Articles

The Potent PI3K-δ,γ Inhibitor IPI-145 Exhibits Differential Activity In Diffuse Large B-Cell Lymphoma (DLBCL) Cell Lines

Veronica Campbell, BS, Ryan Thompson, PhD, Vivian Villegas, MS, Jennifer Proctor, B.S., Karen McGovern, PhD, Jeffery L. Kutok, MD, PhD, Howard M. Stern, M.D., Ph.D.
Journal: Blood
Blood (2013) 122 (21): 1832.
https://doi.org/10.1182/blood.V122.21.1832.1832
Published: 2013
Journal Articles

Preliminary Safety and Efficacy Of IPI-145, a Potent Inhibitor Of Phosphoinositide-3-Kinase-δ,γ, In Patients With Chronic Lymphocytic Leukemia

Ian Flinn, MD, PhD, Manish Patel, MD, Brad S. Kahl, MD, Steven M. Horwitz, MD, Francine M. Foss, MD, Yasuhiro Oki, MD, Pierluigi Porcu, MD, Jennifer Sweeney, BS, Kerstin Allen, MA, Kerrie Faia, MS, Patricia Harris, MPH, Joi Dunbar, PharmD, Howard M. Stern, M.D., Ph.D., Patrick Kelly, MD, Susan O'Brien, MD
Journal: Blood
Blood (2013) 122 (21): 677.
https://doi.org/10.1182/blood.V122.21.677.677
Published: 2013